Development of a dual inhibitor of pan-RAF and VEGFR2 for the treatment of metastatic colorectal cancer with mutant K-RAS

被引：0
|
作者：
Hong, Sungpyo
Choi, Young-Il
Choi, Jihye
Kim, Wonyoung
Kwon, Ho-Seok
Park, Yong Bin
Ki, Min-Hyo
Shin, Hee Jong
Lee, Michael
Ahn, Soon Kil
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-3782
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3782
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Development of a dual inhibitor of pan-RAF and angiogenesis for the treatment of metastatic colorectal cancer with mutant K-RAS
    Hong, Sungpyo
    Choi, Younghoon
    Kwon, Ho-Seok
    Park, Yong Bin
    Ki, Min-Hyo
    Shin, Hee Jong
    Lee, Michael
    Ahn, Soon Kil
    CANCER RESEARCH, 2017, 77
  • [2] Discovery of dual inhibitors of pan-RAF and VEGFR2
    Park, Eun Sun
    Choi, Jihye
    Hong, Sung Pyo
    Kwon, Ho-Seok
    Kim, Jinho
    Ahn, Soon Kil
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2023, 44 (10) : 841 - 847
  • [3] Improvement of the metabolic stability of pan-RAF/VEGFR2 dual inhibitors
    Maiti, Santanu
    Kwon, Jeong Hee
    Hong, Sung Pyo
    Kwon, Ho-Seok
    Kim, Jinho
    Ahn, Soon Kil
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2023, 44 (11) : 926 - 931
  • [4] K-ras mutation status correlates with the expression of VEGFR1, VEGFR2, and PDGFRα in colorectal cancer
    Schimanski, Carl C.
    Zimmermann, Tim
    Schmidtmann, Irene
    Gockel, Ines
    Lang, Hauke
    Galle, Peter R.
    Moehler, Markus
    Berger, Martin R.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2010, 25 (02) : 181 - 186
  • [5] K-ras mutation status correlates with the expression of VEGFR1, VEGFR2, and PDGFRα in colorectal cancer
    Carl C. Schimanski
    Tim Zimmermann
    Irene Schmidtmann
    Ines Gockel
    Hauke Lang
    Peter R. Galle
    Markus Moehler
    Martin R. Berger
    International Journal of Colorectal Disease, 2010, 25 : 181 - 186
  • [6] The role of K-RAS and B-RAF mutations as biomarkers in metastatic colorectal cancer
    Selcukbiricik, F.
    Erdamar, S.
    Ozkurt, C. U.
    Mandel, N. Molinas
    Demirelli, F.
    Ozguroglu, M.
    Tural, D.
    Buyukunal, E.
    Serdengecti, S.
    JOURNAL OF BUON, 2013, 18 (01): : 116 - 123
  • [7] Dual inhibitor of immunokinase and pan-RAF for the treatment of KRAS-mutated cancers
    Hong, Sungpyo
    Ahn, Soon Kil
    Kwon, Ho-Seok
    Park, Yongbin
    Ki, Min-Hyo
    Shin, Hee Jong
    CANCER RESEARCH, 2018, 78 (13)
  • [8] Discovery of a highly potent pan-RAF inhibitor IHMT-RAF-128 for cancer treatment
    Wang, Aoli
    Liu, Juan
    Li, Xixiang
    Zou, Fengming
    Qi, Ziping
    Qi, Shuang
    Liu, Qingwang
    Wang, Zuowei
    Cao, Jiangyan
    Jiang, Zongru
    Wang, Beilei
    Ge, Juan
    Wang, Li
    Wang, Wenchao
    Liu, Jing
    Liu, Qingsong
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 952
  • [9] The Biology of K-Ras and B-Raf Mutations in Colorectal Cancer
    Jiang, Yixing
    Mackley, Heath
    Cheng, Hua
    Ajani, Jaffer A.
    CURRENT COLORECTAL CANCER REPORTS, 2010, 6 (04) : 206 - 211
  • [10] K-RAS AND B-RAF MUTATIONS IN PAIRED PRIMARY AND METASTATIC COLORECTAL TUMORS
    Ko, Yoo-Joung
    Kamel-Reid, Suzanne
    Rowsell, Corwyn
    Zhang, Liying
    Yarom, Nirit
    Jonker, Derek
    ANNALS OF ONCOLOGY, 2011, 22 : v26 - v26
12345